Eintrag weiter verarbeiten
Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant)
Gespeichert in:
| Zeitschriftentitel: | Case Reports in Hematology |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , |
| In: | Case Reports in Hematology, 2015, 2015, S. 1-4 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Hindawi Limited
|
| Schlagwörter: |
| author_facet |
Savini, P. Rondoni, M. Poletti, G. Lanzi, A. Quercia, O. Soverini, S. De Benedittis, C. Musardo, G. Martinelli, G. Stefanini, G. F. Savini, P. Rondoni, M. Poletti, G. Lanzi, A. Quercia, O. Soverini, S. De Benedittis, C. Musardo, G. Martinelli, G. Stefanini, G. F. |
|---|---|
| author |
Savini, P. Rondoni, M. Poletti, G. Lanzi, A. Quercia, O. Soverini, S. De Benedittis, C. Musardo, G. Martinelli, G. Stefanini, G. F. |
| spellingShingle |
Savini, P. Rondoni, M. Poletti, G. Lanzi, A. Quercia, O. Soverini, S. De Benedittis, C. Musardo, G. Martinelli, G. Stefanini, G. F. Case Reports in Hematology Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) Applied Mathematics |
| author_sort |
savini, p. |
| spelling |
Savini, P. Rondoni, M. Poletti, G. Lanzi, A. Quercia, O. Soverini, S. De Benedittis, C. Musardo, G. Martinelli, G. Stefanini, G. F. 2090-6560 2090-6579 Hindawi Limited Applied Mathematics http://dx.doi.org/10.1155/2015/737302 <jats:p>Mast cell leukemia (MCL) is a very rare form of systemic mastocytosis (SM) with a short median survival of 6 months. We describe a case of a 65-year-old woman with aleukaemic variant of MCL with a very high serum total tryptase level of 2255 <jats:italic>μ</jats:italic>g/L at diagnosis, which occurred following an episode of hypotensive shock. She fulfilled the diagnostic criteria of SM, with a bone marrow smear infiltration of 50–60% of atypical mast cells (MCs). She tested negative for the KIT D816V mutation, without any sign of organ damage (no B- or C-findings) and only few mediator-related symptoms. She was treated with antihistamine alone and then with imatinib for the appearance of anemia. She maintained stable tryptase level and a very indolent clinical course for twenty-two months; then, she suddenly progressed to acute MCL with a serum tryptase level up to 12960 <jats:italic>μ</jats:italic>g/L. The patient died due to haemorrhagic diathesis twenty-four months after diagnosis. This clinical case maybe represents an example of the chronic form of mast cell leukemia, described as unpredictable disease, in which the serum total tryptase level has confirmed itself as a reliable marker of mast cells burden regardless of the presence of other signs or symptoms.</jats:p> Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) Case Reports in Hematology |
| doi_str_mv |
10.1155/2015/737302 |
| facet_avail |
Online Free |
| finc_class_facet |
Mathematik |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE1LzczNzMwMg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE1LzczNzMwMg |
| institution |
DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 |
| imprint |
Hindawi Limited, 2015 |
| imprint_str_mv |
Hindawi Limited, 2015 |
| issn |
2090-6560 2090-6579 |
| issn_str_mv |
2090-6560 2090-6579 |
| language |
English |
| mega_collection |
Hindawi Limited (CrossRef) |
| match_str |
savini2015serumtotaltryptaselevelconfirmsitselfasamorereliablemarkerofmastcellsburdeninmastcellleukaemiaaleukaemicvariant |
| publishDateSort |
2015 |
| publisher |
Hindawi Limited |
| recordtype |
ai |
| record_format |
ai |
| series |
Case Reports in Hematology |
| source_id |
49 |
| title |
Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_unstemmed |
Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_full |
Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_fullStr |
Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_full_unstemmed |
Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_short |
Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_sort |
serum total tryptase level confirms itself as a more reliable marker of mast cells burden in mast cell leukaemia (aleukaemic variant) |
| topic |
Applied Mathematics |
| url |
http://dx.doi.org/10.1155/2015/737302 |
| publishDate |
2015 |
| physical |
1-4 |
| description |
<jats:p>Mast cell leukemia (MCL) is a very rare form of systemic mastocytosis (SM) with a short median survival of 6 months. We describe a case of a 65-year-old woman with aleukaemic variant of MCL with a very high serum total tryptase level of 2255 <jats:italic>μ</jats:italic>g/L at diagnosis, which occurred following an episode of hypotensive shock. She fulfilled the diagnostic criteria of SM, with a bone marrow smear infiltration of 50–60% of atypical mast cells (MCs). She tested negative for the KIT D816V mutation, without any sign of organ damage (no B- or C-findings) and only few mediator-related symptoms. She was treated with antihistamine alone and then with imatinib for the appearance of anemia. She maintained stable tryptase level and a very indolent clinical course for twenty-two months; then, she suddenly progressed to acute MCL with a serum tryptase level up to 12960 <jats:italic>μ</jats:italic>g/L. The patient died due to haemorrhagic diathesis twenty-four months after diagnosis. This clinical case maybe represents an example of the chronic form of mast cell leukemia, described as unpredictable disease, in which the serum total tryptase level has confirmed itself as a reliable marker of mast cells burden regardless of the presence of other signs or symptoms.</jats:p> |
| container_start_page |
1 |
| container_title |
Case Reports in Hematology |
| container_volume |
2015 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792325233943773196 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T12:02:20.942Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Serum+Total+Tryptase+Level+Confirms+Itself+as+a+More+Reliable+Marker+of+Mast+Cells+Burden+in+Mast+Cell+Leukaemia+%28Aleukaemic+Variant%29&rft.date=2015-01-01&genre=article&issn=2090-6579&volume=2015&spage=1&epage=4&pages=1-4&jtitle=Case+Reports+in+Hematology&atitle=Serum+Total+Tryptase+Level+Confirms+Itself+as+a+More+Reliable+Marker+of+Mast+Cells+Burden+in+Mast+Cell+Leukaemia+%28Aleukaemic+Variant%29&aulast=Stefanini&aufirst=G.+F.&rft_id=info%3Adoi%2F10.1155%2F2015%2F737302&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792325233943773196 |
| author | Savini, P., Rondoni, M., Poletti, G., Lanzi, A., Quercia, O., Soverini, S., De Benedittis, C., Musardo, G., Martinelli, G., Stefanini, G. F. |
| author_facet | Savini, P., Rondoni, M., Poletti, G., Lanzi, A., Quercia, O., Soverini, S., De Benedittis, C., Musardo, G., Martinelli, G., Stefanini, G. F., Savini, P., Rondoni, M., Poletti, G., Lanzi, A., Quercia, O., Soverini, S., De Benedittis, C., Musardo, G., Martinelli, G., Stefanini, G. F. |
| author_sort | savini, p. |
| container_start_page | 1 |
| container_title | Case Reports in Hematology |
| container_volume | 2015 |
| description | <jats:p>Mast cell leukemia (MCL) is a very rare form of systemic mastocytosis (SM) with a short median survival of 6 months. We describe a case of a 65-year-old woman with aleukaemic variant of MCL with a very high serum total tryptase level of 2255 <jats:italic>μ</jats:italic>g/L at diagnosis, which occurred following an episode of hypotensive shock. She fulfilled the diagnostic criteria of SM, with a bone marrow smear infiltration of 50–60% of atypical mast cells (MCs). She tested negative for the KIT D816V mutation, without any sign of organ damage (no B- or C-findings) and only few mediator-related symptoms. She was treated with antihistamine alone and then with imatinib for the appearance of anemia. She maintained stable tryptase level and a very indolent clinical course for twenty-two months; then, she suddenly progressed to acute MCL with a serum tryptase level up to 12960 <jats:italic>μ</jats:italic>g/L. The patient died due to haemorrhagic diathesis twenty-four months after diagnosis. This clinical case maybe represents an example of the chronic form of mast cell leukemia, described as unpredictable disease, in which the serum total tryptase level has confirmed itself as a reliable marker of mast cells burden regardless of the presence of other signs or symptoms.</jats:p> |
| doi_str_mv | 10.1155/2015/737302 |
| facet_avail | Online, Free |
| finc_class_facet | Mathematik |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE1LzczNzMwMg |
| imprint | Hindawi Limited, 2015 |
| imprint_str_mv | Hindawi Limited, 2015 |
| institution | DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1 |
| issn | 2090-6560, 2090-6579 |
| issn_str_mv | 2090-6560, 2090-6579 |
| language | English |
| last_indexed | 2024-03-01T12:02:20.942Z |
| match_str | savini2015serumtotaltryptaselevelconfirmsitselfasamorereliablemarkerofmastcellsburdeninmastcellleukaemiaaleukaemicvariant |
| mega_collection | Hindawi Limited (CrossRef) |
| physical | 1-4 |
| publishDate | 2015 |
| publishDateSort | 2015 |
| publisher | Hindawi Limited |
| record_format | ai |
| recordtype | ai |
| series | Case Reports in Hematology |
| source_id | 49 |
| spelling | Savini, P. Rondoni, M. Poletti, G. Lanzi, A. Quercia, O. Soverini, S. De Benedittis, C. Musardo, G. Martinelli, G. Stefanini, G. F. 2090-6560 2090-6579 Hindawi Limited Applied Mathematics http://dx.doi.org/10.1155/2015/737302 <jats:p>Mast cell leukemia (MCL) is a very rare form of systemic mastocytosis (SM) with a short median survival of 6 months. We describe a case of a 65-year-old woman with aleukaemic variant of MCL with a very high serum total tryptase level of 2255 <jats:italic>μ</jats:italic>g/L at diagnosis, which occurred following an episode of hypotensive shock. She fulfilled the diagnostic criteria of SM, with a bone marrow smear infiltration of 50–60% of atypical mast cells (MCs). She tested negative for the KIT D816V mutation, without any sign of organ damage (no B- or C-findings) and only few mediator-related symptoms. She was treated with antihistamine alone and then with imatinib for the appearance of anemia. She maintained stable tryptase level and a very indolent clinical course for twenty-two months; then, she suddenly progressed to acute MCL with a serum tryptase level up to 12960 <jats:italic>μ</jats:italic>g/L. The patient died due to haemorrhagic diathesis twenty-four months after diagnosis. This clinical case maybe represents an example of the chronic form of mast cell leukemia, described as unpredictable disease, in which the serum total tryptase level has confirmed itself as a reliable marker of mast cells burden regardless of the presence of other signs or symptoms.</jats:p> Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) Case Reports in Hematology |
| spellingShingle | Savini, P., Rondoni, M., Poletti, G., Lanzi, A., Quercia, O., Soverini, S., De Benedittis, C., Musardo, G., Martinelli, G., Stefanini, G. F., Case Reports in Hematology, Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant), Applied Mathematics |
| title | Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_full | Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_fullStr | Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_full_unstemmed | Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_short | Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| title_sort | serum total tryptase level confirms itself as a more reliable marker of mast cells burden in mast cell leukaemia (aleukaemic variant) |
| title_unstemmed | Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant) |
| topic | Applied Mathematics |
| url | http://dx.doi.org/10.1155/2015/737302 |